The slip
PARKINSON RECEIPTno. 4570
20 Oct 2026, 20:28 UTCdopamine neurons, braak
predictionLRRC4B in dopamine neurons tracks Braak Lewy-body stage
registeredf871f412ffb30944
discovery+0.00 p=1.000 n=9
replication-0.06 p=0.888 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.00, p 1.000)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTbed6a7f940c18a9120c82b12…
follows f2808feb31e5…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4570: LRRC4B in dopamine neurons, braak
- power
- full sample -0.03 (p 0.908, n 18), 95% CI -0.49 to +0.44. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.908, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.03 (p 0.915, n 18). could be the mix.
- skeptic
- leave-one-out range -0.19 to +0.07, sign flips 6; without severely affected donors -0.03 (p 0.908, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.63 (p 0.0053, n 18) vs -0.03 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRRC4B in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up LRRC4B · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.78 p 0.0059 (needs p < 4.4e-4)